1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAN-NCIC-PA1, BAYER-STR-CO2, PA1
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BAYER-12-9566/D97-027, CWRU-BAYR-1597, IMPACT-100009, NCI-V98-1411
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BAYER-12-9566/D97-028, BAYER-12-9566, RPCI-DS-9803
|
|
4.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAN-NCIC-IND107, BAYER-12-9566/STRCPI, IND107
|
|
5.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CAN-NCIC-IND113, BAYER-STR-C01, IND113
|